Clayman Thyroid Center sets 100-case annual minimum for thyroid cancer surgeons

The Clayman Thyroid Center in Tampa has published new 2026 thyroid cancer surgery guidelines that recommend a minimum of 100 thyroid operations a year for surgeons, with best outcomes above 400. The document also urges patients to ask about complication and recurrence rates and sharply diverges from American Thyroid Association advice on prophylactic central neck dissection.

Why it matters: - The guidelines attempt to turn surgeon volume into a patient-facing quality metric for thyroid cancer surgery. - The document argues that higher-volume centers and surgeons can reduce recurrence and complication risk. - The recommendations could influence where patients seek second opinions and where health systems concentrate complex thyroid surgery.

What happened: - The Clayman Thyroid Center at the Hospital for Endocrine Surgery in Tampa published the 2026 Clinical Practice Guidelines: Surgical Management of Differentiated Thyroid Cancer. - The guidelines are based on more than 40,000 thyroid cancer operations and prospective outcomes tracking from 1993 to 2025. - The full document is available here. - The guidelines differ from 2025 American Thyroid Association recommendations on several points.

The details: - The first recommendation sets a minimum surgeon volume of 100 thyroid operations per year for thyroid cancer surgery. - The guidelines say optimal outcomes are associated with surgeons performing more than 400 thyroid operations annually. - The document says most thyroid operations in the United States are performed by surgeons doing fewer than 10 cases per year. - The guidelines recommend that every thyroid cancer surgery center publish annual volume, permanent complication rate and structural recurrence rate at long-term follow-up. - The guidelines call for referral patterns and health system policy to concentrate thyroid cancer surgery at higher-volume centers. - The guidelines recommend prophylactic central neck dissection for all clinically staged differentiated thyroid cancers, including T1 and T2 tumors, when performed at a high-volume center with immediate intraoperative frozen section pathology available. - The 2025 ATA guidelines advise against prophylactic central neck dissection for clinically node-negative T1 and T2 tumors. - The guidelines make frozen section pathology mandatory for central compartment dissections, saying results in 7 to 15 minutes can guide the extent of surgery. - The document cites a 20-year structural recurrence rate of 0.2% and a permanent complication rate of 0.4% in the center's single-institution series. - The guidelines present comparison data from national and international registries alongside the center's outcomes. - The authors say the recommendations depend on infrastructure that most hospitals do not have, including high surgical volume, immediate expert frozen section pathology, a dedicated endocrine pathology team, systematic nerve monitoring and long-term follow-up. - Centers without that infrastructure should follow ATA recommendations, the document states.

Between the lines: - The guidelines are as much a position paper on surgical centralization as they are a treatment document. - Clayman Thyroid Center is using its outcomes to argue that national guidance is too conservative for high-volume settings. - The emphasis on patient-checkable metrics suggests the center wants patients to ask harder questions before choosing a surgeon. - The document also tries to limit overreach by saying its recommendations do not apply to most hospitals.

What's next: - The guidelines invite other high-volume centers to contribute prospective outcomes data to a multi-center registry. - The authors plan peer-reviewed manuscripts on the volume-outcome analysis and observational cohort. - The document is scheduled for review in August 2028. - The center says patients should seek second opinions for recurrent or persistent disease, lateral neck lymph node metastases, invasive tumors, complications from prior thyroid surgery, familial thyroid cancer syndromes or when a surgeon performs fewer than 100 thyroid operations per year. - During Thyroid Cancer Awareness Month, the center is also promoting its “Know Your Neck” message and points patients to more information and a video demonstration.

The bottom line: - Clayman Thyroid Center is trying to redefine thyroid cancer surgery around surgeon volume, outcomes tracking and higher-acuity referral patterns, while drawing a clear line between what it believes works in elite centers and what most hospitals can safely do.